We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

CEPI Grants Funding to INOVIO for Phase I/II Trial of COVID-19 Vaccine

Product News   Apr 16, 2020 | Original story from INOVIO

 
CEPI Grants Funding to INOVIO for Phase I/II Trial of COVID-19 Vaccine
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Corning Adds 3D Clear Tissue Clearing Reagent to 3D Cell Culture Imaging Portfolio

Product News

Corning Incorporated announced the launch of its 3D Clear Tissue Clearing Reagent, a product designed for rapid and easy imaging of tissues in 3D cell culture without damaging the underlying cellular morphology.

READ MORE

Intravacc and Celonic to Develop and Produce a Novel COVID-19 Vaccine

Product News

Intravacc and Celonic have announced that they have signed a research agreement to further design, develop and produce a COVID-19 vaccine based on an immunogenic Spike (S) protein of SARS-CoV-2 combined with Intravacc’s proprietary Outer Membrane Vesicle (OMV) technology.

READ MORE

Medidata Supports Moderna’s COVID-19 Vaccine Clinical Trials with Rave Clinical Cloud Platform

Product News

Medidata is collaborating with Moderna, Inc. to support clinical trials of mRNA-1273, Moderna’s COVID-19 vaccine candidate.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Proteomics & Metabolomics Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE